Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis
Authors:
- 14 March 2003
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (3) , 274-279
Abstract
Systemic sclerosis is accompanied by an influx of activated phagocytes into distal airways. These cells release H2O2, which may evaporate from the airways surface and be detected in expired breath condensate. We tested whether patients with systemic sclerosis exhale more H2O2 than healthy subjects and whether breath condensate H2O2 levels correlate with some clinical parameters. H2O2 was measured fluorimetrically in the expired breath condensate of 27 patients (22 women, five men, mean age 49 +/- 13.1 years) with systemic sclerosis and 27 age- and sex- matched healthy controls. Exhaled H2O2 levels were 3.5-fold higher (0.88 +/- 0.62 microM vs. 0.25 +/- 0.17 microM, P < 0.001) in the patients with systemic sclerosis than in the controls. Treatment with cyclophosphamide and/or prednisone (29 +/- 50 months, range 3-168 months) did not significantly decrease H2O2 exhalation (0.78 +/- 0.50 microM, n= 10 vs. 0.94 +/- 0.67 microM, n= 17, P > 0.05). No significant difference was found between patients with limited and diffuse scleroderma (1.03 +/- 0.69 microM, n= 17 vs. 0.63 +/- 0.41 microM, n= 10, P > 0.05). H2O2 levels correlated with disease duration (r = 0.38, P < 0.05) and time from the first Raynaud's episode (r = 0.44, P < 0.05). Patients with systemic sclerosis exhale more H2O2 than healthy controls, suggesting involvement of reactive oxygen species in disease processes. Lack of significant intergroups differences in H2O2 levels may have resulted from the small number of patients analyzed.Keywords
This publication has 33 references indexed in Scilit:
- Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosisArthritis & Rheumatism, 2001
- Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary diseaseRespiratory Medicine, 2001
- European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centresAnnals of the Rheumatic Diseases, 2001
- Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patientsRespiratory Medicine, 2000
- Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smokingRespiratory Medicine, 1999
- Monocytes of Patients with Systemic Sclerosis (Scleroderma) Spontaneously Release In Vitro Increased Amounts of Superoxide AnionJournal of Investigative Dermatology, 1999
- Elevated Levels of Expired Breath Hydrogen Peroxide in BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Increased content of hydrogen peroxide in the expired breath of cigarette smokersEuropean Respiratory Journal, 1996
- Structural Features of Interstitial Lung Disease in Systemic SclerosisAmerican Review of Respiratory Disease, 1991
- Increased chemiluminescence of polymorphonuclear leucocytes from patients with progressive systemic sclerosisClinical Science, 1986